Following a top-heavy 2025, macro tailwinds are increasing for the middle market, which had a tepid end to a promising 2H25. “Over the last couple of years healthcare M&A has been relatively muted – pressured by higher rates, valuation gaps, and regulatory uncertainty. We’re now seeing that start to change,” said Matt Bennett, partner at Invidia Capital Management. “Financing markets have improved, bid-ask spreads are narrowing, and the policy backdrop is becoming clearer and more predictable; this is giving both strategics and sponsors more confidence to transact.”
Read the full article: North America Mid‑Market Healthcare Scrubs in for High‑Volume 2026 //
Source: https://ionanalytics.com/insights/mergermarket/north-america-mid-market-healthcare-scrubs-in-for-high-volume-2026/